𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Model for End-stage Liver Disease and Model for End-stage Liver Disease-Na Scores Predict Both Before-Listing and Wait-List Mortality

✍ Scribed by N. Yamashiki; Y. Sugawara; S. Tamura; J. Kaneko; K. Nojiri; T. Aoki; Y. Sakamoto; K. Hasegawa; K. Koike; N. Kokudo


Book ID
113935423
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
435 KB
Volume
44
Category
Article
ISSN
0041-1345

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


End-stage liver disease candidates at th
✍ Pratima Sharma; Douglas E. Schaubel; Qi Gong; Mary Guidinger; Robert M. Merion πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 385 KB

Candidates with fulminant hepatic failure (Status-1A) receive the highest priority for liver transplantation (LT) in the United States. However, no studies have compared wait-list mortality risk among end-stage liver disease (ESLD) candidates with high Model for End-Stage Liver Disease (MELD) scores

Clinically relevant differences in the M
✍ Rhiana Garritsen; Andrei Tintu; Herold Metselaar; Geert Kazemier πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 1 views

With interest, we read the article by Xiol et al. 1 regarding differences in serum measurements between different laboratories and their influence on the Model for End-Stage Liver Disease (MELD) and the Model for End-Stage Liver Disease incorporating serum sodium (MELD-Na). They reported significant